Effects of plasma from patients with acute on chronic liver failure on function of cytochrome P450 in immortalized human hepatocytes

被引:0
|
作者
Wei-Bo Du
机构
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
acute on chronic liver failure; bioartificial liver; immortalized human hepatocyte; cytochrome P450; cell culture;
D O I
暂无
中图分类号
R575.3 [肝功能衰竭];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND:The bioartificial liver is anticipated to be a promising alternative choice for patients with liver failure. Toxic substances which accumulate in the patients’plasma exert deleterious effects on hepatocytes in the bioreactor,and potentially reduce the efficacy of bioartificial liver devices. This study was designed to investigate the effects of plasma from patients with acute on chronic liver failure(AoCLF)on immortalized human hepatocytes in terms of cytochrome P450 gene expression,drug metabolism activity and detoxification capability. METHODS:Immortalized human hepatocytes(HepLi-2 cells)were cultured in medium containing fetal calf serum or human plasma from three patients with AoCLF.The cytochrome P450(CYP3A5,CYP2E1,CYP3A4)expression, drug metabolism activity and detoxification capability of HepLi-2 cells were assessed by RT-PCR,lidocaine clearance and ammonia elimination assay. RESULTS:After incubation in medium containing AoCLF plasma for 24 hours,the cytochrome P450 mRNA expression of HepLi-2 cells was not significantly decreased compared with control culture.Ammonia elimination and lidocaine clearance assay showed that the ability of ammonia removal and drug metabolism remained stable. CONCLUSIONS:Immortalized human hepatocytes can be exposed to AoCLF plasma for at least 24 hours with no significant reduction in the function of cytochrome P450. HepLi-2 cells appear to be effective in metabolism and detoxification and can be potentially used in the development of bioartificial liver.
引用
收藏
页码:611 / 614
页数:4
相关论文
共 50 条
  • [31] Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure
    Tao, Ya-Chao
    Wang, Meng-Lan
    Wang, Ming
    Ma, Yuan-Ji
    Bai, Lang
    Feng, Ping
    Chen, En-Qiang
    Tang, Hong
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (03) : 412 - 418
  • [32] Safety and Efficacy of Regional Citrate Anticoagulation during Plasma Adsorption Plus Plasma Exchange Therapy for Patients with Acute-on-Chronic Liver Failure: A Pilot Study
    Ma, Yuanji
    Chen, Fang
    Xu, Yan
    Wang, Ming
    Zhou, Taoyou
    Lu, Jiajie
    Feng, Ping
    Wang, Ying
    Bai, Lang
    Tang, Hong
    BLOOD PURIFICATION, 2019, 48 (03) : 223 - 232
  • [33] HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity
    van Wenum, Martien
    Treskes, Philipp
    Adam, Aziza A. A.
    van der Mark, Vincent. A.
    Jongejan, Aldo
    Moerland, Perry D.
    van Gulik, Thomas M.
    Elferink, Ronald P. J. Oude
    Chamuleau, Robert A. F. M.
    Hoekstra, Ruurdtje
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 48 (05) : 2189 - 2204
  • [34] The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells
    Shi, Q
    Gaylor, JDS
    Cousins, R
    Plevris, T
    Hayes, PC
    Grant, MH
    ARTIFICIAL ORGANS, 1998, 22 (12) : 1023 - 1030
  • [35] Design for a Multicentre Prospective Cohort for the Assessment of Platelet Function in Patients with Hepatitis-B-Virus-Related Acute-on-Chronic Liver Failure
    Jiang, Xiuhua
    Chai, Shiqi
    Huang, Yan
    Huang, Zuxiong
    Tan, Wenting
    Gao, Yanhang
    Lu, Xiaobo
    Meng, Zhongji
    Zhou, Huayou
    Kong, Wenbing
    Tang, Xiaoting
    Tang, Yujun
    Qi, Tingting
    Liao, Chengjin
    Gan, Qiaorong
    Xiang, Xiaomei
    Zhang, Yanan
    Wang, Shuai
    Chen, Yuanyuan
    Chen, Jinjun
    CLINICAL EPIDEMIOLOGY, 2022, 14 : 997 - 1011
  • [36] Muscle function is superior to muscle mass in predicting 90-day mortality in patients with acute-on-chronic liver failure: A prospective study
    Geng, Nan
    Kong, Ming
    Chen, Huina
    Zhang, Jiateng
    Xu, Manman
    Song, Wenyan
    Chen, Yu
    Duan, Zhongping
    NUTRITION, 2024, 118
  • [37] Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure
    Yao, Jia
    Li, Shuang
    Zhou, Li
    Luo, Lei
    Yuan, Lili
    Duan, Zhongping
    Xu, Jun
    Chen, Yu
    JOURNAL OF CLINICAL APHERESIS, 2019, 34 (04) : 392 - 398
  • [38] Changes in Peripheral CD4+CD25high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment
    Mao, Wei-lin
    Lou, Yu-Feng
    Ye, Bo
    Lin, Sha
    Chen, Yue-mei
    Chen, Yu
    INFLAMMATION, 2012, 35 (02) : 436 - 444
  • [39] Changes in Peripheral CD4+CD25high Regulatory T Cells in the Acute-on-Chronic Liver Failure Patients with Plasma Exchange Treatment
    Wei-lin Mao
    Yu-Feng Lou
    Bo Ye
    Sha Lin
    Yue-mei Chen
    Yu Chen
    Inflammation, 2012, 35 : 436 - 444
  • [40] Double Plasma Molecular Adsorption System with Sequential Low-dose Plasma Exchange in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure: A Prospective Study
    Wang, Lu
    Xu, Wenxiong
    Zhu, Shu
    Lin, Guoli
    Lai, Jing
    Zhang, Yufeng
    Liu, Ying
    Zheng, Lihua
    Luo, Qiumin
    Gao, Zhiliang
    Xie, Chan
    Peng, Liang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (04) : 908 - 917